TrialAnnals of the rheumatic diseases2017

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.

Marc Humbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.